KR880001638B1 - 항종양성 항생물질 루조펩틴 e₂ 및 그 제조방법 - Google Patents

항종양성 항생물질 루조펩틴 e₂ 및 그 제조방법 Download PDF

Info

Publication number
KR880001638B1
KR880001638B1 KR1019840000383A KR840000383A KR880001638B1 KR 880001638 B1 KR880001638 B1 KR 880001638B1 KR 1019840000383 A KR1019840000383 A KR 1019840000383A KR 840000383 A KR840000383 A KR 840000383A KR 880001638 B1 KR880001638 B1 KR 880001638B1
Authority
KR
South Korea
Prior art keywords
luzopeptin
methionine
cysteine
strain
medium
Prior art date
Application number
KR1019840000383A
Other languages
English (en)
Korean (ko)
Other versions
KR840007106A (ko
Inventor
에이. 클라리즈 차알스
슈미츠 헨리
더블유. 도일 테렌스
에프. 컴머 마리안
Original Assignee
브리스톨-마이어즈 컴페니
아이삭 자아코브스키
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브리스톨-마이어즈 컴페니, 아이삭 자아코브스키 filed Critical 브리스톨-마이어즈 컴페니
Publication of KR840007106A publication Critical patent/KR840007106A/ko
Application granted granted Critical
Publication of KR880001638B1 publication Critical patent/KR880001638B1/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019840000383A 1983-01-31 1984-01-28 항종양성 항생물질 루조펩틴 e₂ 및 그 제조방법 KR880001638B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46257783A 1983-01-31 1983-01-31
US462.577 1983-01-31
US462577 1983-01-31

Publications (2)

Publication Number Publication Date
KR840007106A KR840007106A (ko) 1984-12-05
KR880001638B1 true KR880001638B1 (ko) 1988-09-03

Family

ID=23836950

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840000383A KR880001638B1 (ko) 1983-01-31 1984-01-28 항종양성 항생물질 루조펩틴 e₂ 및 그 제조방법

Country Status (15)

Country Link
JP (1) JPH0645638B2 (sv)
KR (1) KR880001638B1 (sv)
AU (1) AU566569B2 (sv)
BE (1) BE898807A (sv)
CA (1) CA1220746A (sv)
CH (1) CH663415A5 (sv)
DE (1) DE3403125A1 (sv)
FR (1) FR2540116B1 (sv)
GB (1) GB2134119B (sv)
GR (1) GR81749B (sv)
IT (1) IT1175927B (sv)
MY (1) MY8800015A (sv)
NL (1) NL8400237A (sv)
SE (1) SE464582B (sv)
ZA (1) ZA84613B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643871A (en) * 1993-11-23 1997-07-01 Bristol-Meyers Squibb Company Antitumor antibiotics
GB2294265A (en) * 1994-10-20 1996-04-24 Merck & Co Inc Cyclic depsipeptides obtained from Actinomycete sp.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2050384B (en) * 1979-04-02 1983-04-07 Bristol Myers Co Antitumor antibacterial agents

Also Published As

Publication number Publication date
SE464582B (sv) 1991-05-13
JPS59173091A (ja) 1984-09-29
JPH0645638B2 (ja) 1994-06-15
SE8400450L (sv) 1984-08-01
GR81749B (sv) 1984-12-12
GB2134119A (en) 1984-08-08
DE3403125A1 (de) 1984-10-31
AU566569B2 (en) 1987-10-22
FR2540116B1 (fr) 1989-08-18
CH663415A5 (de) 1987-12-15
SE8400450D0 (sv) 1984-01-30
NL8400237A (nl) 1984-08-16
IT1175927B (it) 1987-08-12
IT8419348A0 (it) 1984-01-27
BE898807A (fr) 1984-07-31
GB2134119B (en) 1986-04-30
ZA84613B (en) 1984-09-26
FR2540116A1 (fr) 1984-08-03
CA1220746A (en) 1987-04-21
AU2372184A (en) 1984-08-02
MY8800015A (en) 1988-12-31
GB8402410D0 (en) 1984-02-29
KR840007106A (ko) 1984-12-05

Similar Documents

Publication Publication Date Title
JP3140228B2 (ja) 新規な大環状ラクトンおよびその生産菌
KR900004066B1 (ko) 생물학적으로 활성인 ws 6049의 제조방법
GB2220657A (en) Antifungal fermentation product
KR960013432B1 (ko) 항균제 fr109615 및 이의 제조방법
JPS5910798B2 (ja) 新しいリフアマイシン類の製造方法
JPS63139191A (ja) 抗腫瘍抗菌剤
KR880001638B1 (ko) 항종양성 항생물질 루조펩틴 e₂ 및 그 제조방법
JPH07102128B2 (ja) ストレプトミセス・サンダエンシスの生物学的純粋培養物
JPS5948992B2 (ja) 抗生物質ｃ−１４４８２ａ↓１
JPS625990A (ja) 抗生物質およびその製造方法
US5281417A (en) Antitumor process employing novel fermentate of an Actinomadura strain
EP0109750B1 (en) Nargenicin c1
EP0187049A2 (en) Micromonospora microorganisms and macrolide antibiotic production therewith
JP3830964B2 (ja) 海洋放線菌から単離した新規なチオデプシペプチド
US4628046A (en) Antibiotic LL-C23201δ
RU2057181C1 (ru) Способ получения антибиотика прадимицина, штамм actinomadura species - продуцент прадимицина
EP0413967B1 (en) Novel antibiotic
DE68903507T2 (de) Antitumor-antibiotika.
US4956283A (en) Process for preparing macrolide antibiotics by culturing streptomyces hirsutus ATCC 53513
KR0130473B1 (ko) 새로운 항생물질, 베나노마이신 a와 b 및 덱실오실베나노마이신 b와 이들의 제조 방법과 용도
RU2120997C1 (ru) Способ получения 2-амино-4(гидроксиметил)-3а,5,6,6а-тетрагидро-4h-циклопент-[d]-оксазол-4, 5,6-триола и продуцирующие его штаммы актиномицета micromonospora и актиномицета amycolatopsis
KR830001245B1 (ko) 항생물질 마이코플라네신의 제조방법
JP4755248B2 (ja) 新規な抗生物質、ビスポライドＡ１、Ａ２およびＡ３ならびにビスポライドＢ１、Ｂ２ａ、Ｂ２ｂおよびＢ３と、それら抗生物質の製造方法
JP3641050B2 (ja) 新規な生理活性物質ｋ９３−０７１１ ｉ−１及びｉ−２並びにそれらの製造法
IE54813B1 (en) Microorganism actinomadura yumaense sp.nov. and use thereof to prepare antibiotics ll-c23024 alpha, beta and iota

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19930811

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee